AHCPR CONSIDERING FORMATION OF TECHNOLOGY ASSESSMENT CONSORTIUM
This article was originally published in The Gray Sheet
Executive Summary
AHCPR CONSIDERING FORMATION OF TECHNOLOGY ASSESSMENT CONSORTIUM composed of government, industry, academia, and health care provider representatives, Lisa Simpson, MD, a senior policy analyst in the Agency for Health Care Policy and Research, said at a Sept. 20 meeting of the National Association for Medical Equipment Services in Washington, D.C. The agency, according to Simpson, is planning to form a consortium that would "come together to conduct [technology] assessments, make available the results of those assessments, and provide technical assistance to purchasers, providers, and certified payers in judging the value" of adopting new technologies for "modified benefits packages."
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.